TerSera Therapeutics - M&A Summary and Business Overview

Life ScienceCompany

TerSera Therapeutics M&A Summary

TerSera Therapeutics has acquired 2 companies, including 2 in the last 5 years.

TerSera Therapeutics’ largest acquisition to date was in 2020, when it acquired Lexicon Pharmaceuticals - XERMELO for $159M. TerSera Therapeutics has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

TerSera Therapeutics Business Overview

Where is TerSera Therapeutics headquartered?

TerSera Therapeutics is headquartered in Lake Forest, Illinois.

What sector is TerSera Therapeutics in?

TerSera Therapeutics is a life science company.

When was TerSera Therapeutics founded?

TerSera Therapeutics was founded in 2016.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

TerSera Therapeutics

TerSera Therapeutics LLC

150 N Field Dr, Suite 195,
Lake Forest, Illinois 60045
United States,
(888) 600-8116
www.tersera.com

TerSera Therapeutics is a specialty pharmaceutical company focused on therapeutics to improve patient outcomes. The company was formed to acquire specialty pharmaceutical companies and products with a focus on select physician specialties. TerSera Therapeutics was founded in 2016 and is based in Lake Forest, Illinois.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # - 1 - - - 1 2
vol $159M $159M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
MARGENZA 2024-10-22 - Divestiture
Rockville, Maryland · www.celestial.ai
Lexicon Pharmaceuticals, Inc. - XERMELO 2020-07-30 159M USD Divestiture
The Woodlands, Texas · www.xermelo.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 159M (100%) - -
Total 2 $159M - -

By Geo

State/Country Buy Value Sell Value
United States 2 159M - -
  Texas 1 159M - -
  Maryland 1 - - -
Total 2 $159M - -

Deal Values

buy # Total
$100M to $1B 1 $159M
TOTAL $159M
Largest Lexicon Pharmaceuticals, Inc. - XERMELO
$159M (2020-07-30)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
2 (100%)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.